GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allmed Solutions Ltd (XTAE:ALMD) » Definitions » EV-to-Revenue

Allmed Solutions (XTAE:ALMD) EV-to-Revenue : (As of Jun. 13, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Allmed Solutions EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Allmed Solutions's enterprise value is ₪-22.59 Mil. Allmed Solutions's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.00 Mil. Therefore, Allmed Solutions's EV-to-Revenue for today is .

The historical rank and industry rank for Allmed Solutions's EV-to-Revenue or its related term are showing as below:

During the past 13 years, the highest EV-to-Revenue of Allmed Solutions was 16.36. The lowest was 0.39. And the median was 3.38.

XTAE:ALMD's EV-to-Revenue is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 3.14
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-13), Allmed Solutions's stock price is ₪0.31. Allmed Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.00. Therefore, Allmed Solutions's PS Ratio for today is .


Allmed Solutions EV-to-Revenue Historical Data

The historical data trend for Allmed Solutions's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allmed Solutions EV-to-Revenue Chart

Allmed Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.01 3.62 3.98 - -

Allmed Solutions Semi-Annual Data
Dec12 Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.98 - - - -

Competitive Comparison of Allmed Solutions's EV-to-Revenue

For the Medical Devices subindustry, Allmed Solutions's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allmed Solutions's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allmed Solutions's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Allmed Solutions's EV-to-Revenue falls into.



Allmed Solutions EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Allmed Solutions's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-22.593/0
=

Allmed Solutions's current Enterprise Value is ₪-22.59 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Allmed Solutions's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allmed Solutions  (XTAE:ALMD) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Allmed Solutions's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.31/0
=

Allmed Solutions's share price for today is ₪0.31.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was ₪0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allmed Solutions EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Allmed Solutions's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Allmed Solutions (XTAE:ALMD) Business Description

Traded in Other Exchanges
N/A
Address
2 Ha-Eshel Street, P.O.BOX 3081, Caesarea Industrial Park, Caesarea, ISR, 3079501
Allmed Solutions Ltd is a medical device company. It researches, develops, manufactures and markets peripheral stents and medical devices. It has developed a proprietary stent technology platform to expedite the development of site-specific stents. It also develops medical devices focused on minimal invasive therapy for the treatment of type 2 diabetes.

Allmed Solutions (XTAE:ALMD) Headlines

No Headlines